AU2001272849A1 - Composition for the treatment of osteoarthritis - Google Patents
Composition for the treatment of osteoarthritisInfo
- Publication number
- AU2001272849A1 AU2001272849A1 AU2001272849A AU7284901A AU2001272849A1 AU 2001272849 A1 AU2001272849 A1 AU 2001272849A1 AU 2001272849 A AU2001272849 A AU 2001272849A AU 7284901 A AU7284901 A AU 7284901A AU 2001272849 A1 AU2001272849 A1 AU 2001272849A1
- Authority
- AU
- Australia
- Prior art keywords
- osteoarthritis
- treatment
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61356200A | 2000-07-10 | 2000-07-10 | |
US09/613,562 | 2000-07-10 | ||
PCT/NL2001/000525 WO2002004003A2 (en) | 2000-07-10 | 2001-07-10 | Composition for the treatment of osteoarthritis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001272849A1 true AU2001272849A1 (en) | 2002-01-21 |
Family
ID=24457782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001272849A Abandoned AU2001272849A1 (en) | 2000-07-10 | 2001-07-10 | Composition for the treatment of osteoarthritis |
Country Status (4)
Country | Link |
---|---|
US (1) | US6492429B1 (en) |
EP (1) | EP1347766A2 (en) |
AU (1) | AU2001272849A1 (en) |
WO (1) | WO2002004003A2 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7799766B2 (en) * | 1998-04-08 | 2010-09-21 | Theta Biomedical Consulting & Development Co., Inc. | Composition for treating hormonally-dependent cancers |
US6984667B2 (en) * | 1998-04-08 | 2006-01-10 | Theta Biomedical Consulting And Development Co. | Synergistic proteoglycan compositions for inflammatory conditions |
US6534086B1 (en) * | 2000-03-06 | 2003-03-18 | Metagenics, Inc. | Composition and method for treatment of inflammation and pain in mammals |
GB2368012A (en) * | 2000-10-19 | 2002-04-24 | Nicholas John Larkins | Preparation for the relief of inflammatory disease |
US20040043013A1 (en) | 2000-12-28 | 2004-03-04 | Mccleary Edward Larry | Metabolic uncoupling therapy |
US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US8168234B2 (en) | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US20040115290A1 (en) * | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US8142819B2 (en) | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7901714B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
WO2003002125A2 (en) * | 2001-06-29 | 2003-01-09 | Astion A/S | Combination of aminosugars and cysteine or cysteine derivatives |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
US6949586B2 (en) * | 2002-02-11 | 2005-09-27 | Council Of Scientific Research | Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity |
US20030199581A1 (en) * | 2002-03-13 | 2003-10-23 | Seligson Allen L. | Boswellin compositions enhanced with 3-beta-acetyl-11-keto-beta-boswellic acid ("AKBA") industrial manufacture and uses |
WO2003080081A2 (en) * | 2002-03-25 | 2003-10-02 | Council Of Scientific And Industrial Research | Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof |
GB0209254D0 (en) * | 2002-04-23 | 2002-06-05 | Larkins Nicholas J | Preparation for the relief of disease |
WO2004037180A2 (en) | 2002-10-21 | 2004-05-06 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7018663B2 (en) | 2002-11-21 | 2006-03-28 | Donald E. Scott | Application of dried nettle to the skin |
AU2004216541A1 (en) * | 2003-02-28 | 2004-09-10 | Howard Florey Institute Of Experimental Physiology And Medicine | Therapeutic compositions |
US8703209B2 (en) * | 2003-06-17 | 2014-04-22 | Edward Larry McCleary | Composition and method for modulating hydrogen ion physiology |
EP1502594A1 (en) * | 2003-07-31 | 2005-02-02 | Pynogin GmbH | A health care composition for decreasing the risk of thrombosis including a mixture of proanthocyanidins and sesquiterpenes |
KR101245440B1 (en) * | 2003-09-12 | 2013-03-19 | 액세스 비지니스 그룹 인터내셔날 엘엘씨 | Cytokine modulators and related method of use |
US7758903B2 (en) | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
US7758902B2 (en) * | 2003-09-12 | 2010-07-20 | Access Business Group International Llc | Cytokine modulators and related methods of use |
US20090169585A1 (en) * | 2003-10-23 | 2009-07-02 | Resveratrol Partners, Llc | Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity |
US20050158376A1 (en) * | 2003-10-23 | 2005-07-21 | Sardi William F. | Dietary supplement and method of processing same |
US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
WO2005110431A1 (en) * | 2004-05-19 | 2005-11-24 | University Of Manitoba | Herbal product containing glucosamine |
US7455860B2 (en) * | 2004-08-11 | 2008-11-25 | Laila Nutraceuticals | Dietary supplement formulation for controlling inflammation and cancer |
ITRM20040439A1 (en) * | 2004-09-16 | 2004-12-16 | Ca Di Group S R L | PRODUCT WITH SELECTIVE ANTI-INFLAMMATORY ACTION AND ACTION AGAINST TISSUE FIBROGENESIS. |
US20060246115A1 (en) * | 2005-03-04 | 2006-11-02 | Ricardo Rueda | Nutritional products for ameliorating symptoms of rheumatoid arthritis |
GB2424833B (en) * | 2005-04-08 | 2008-12-10 | Nicholas John Larkins | Anti-inflammatory formulation comprising apocyanin and paeonol |
US7956031B2 (en) | 2005-05-31 | 2011-06-07 | Naidu Lp | Metallo-lactoferrin-coenzyme compositions for trigger and release of bioenergy |
EP1928248A4 (en) | 2005-08-09 | 2009-09-16 | Metaproteomics Llp | Protein kinase modulation by hops and acacia products |
US20070071809A1 (en) * | 2005-09-26 | 2007-03-29 | Vad Vijay B | Ginger containing compositions to control pain |
AU2006332728A1 (en) * | 2005-12-30 | 2007-07-12 | University Of Iowa Research Foundation | Method of identifying compounds useful to treat neuronal degenerative diseases |
GB2436063A (en) * | 2006-03-16 | 2007-09-19 | Nicholas John Larkins | Pharmaceutical composition for the treatment of excess mucous production |
US8021659B2 (en) | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
EP1925301A1 (en) * | 2006-11-24 | 2008-05-28 | DSMIP Assets B.V. | Use of tricyclic diterpenes and their derivatives for the treatment, co-treatment or prevention of inflammatory disorders and/or joint disorders |
US20080167277A1 (en) * | 2006-12-29 | 2008-07-10 | Charles Conrad | Methods of treating skin disorders with caffeic acid analogs |
CA2686043A1 (en) | 2007-05-11 | 2008-11-20 | Metaproteomics, Llc | Methods and compositions for heavy metal detoxification |
GB2463080A (en) * | 2008-09-02 | 2010-03-03 | Nicholas John Larkins | Pharmaceutical preparation |
US8450337B2 (en) * | 2008-09-30 | 2013-05-28 | Moleculin, Llc | Methods of treating skin disorders with caffeic acid analogs |
WO2012177825A1 (en) | 2011-06-21 | 2012-12-27 | Bvw Holding Ag | Medical device comprising boswellic acid |
US8916528B2 (en) | 2011-11-16 | 2014-12-23 | Resveratrol Partners, Llc | Compositions containing resveratrol and nucleotides |
MX347457B (en) * | 2012-01-16 | 2017-04-27 | Héctor De Jesús Velez-Rivera | Phytocomposition for the treatment of pain related to joint diseases. |
WO2014138372A1 (en) * | 2013-03-06 | 2014-09-12 | Primavera Biosciences, Inc. | Composition and method for treating osteoarthritis |
US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
WO2016072992A1 (en) * | 2014-11-06 | 2016-05-12 | NWO Stem Cure, LLC | Nutraceutical supplement with lactobacillus rhamnosus |
WO2017139381A1 (en) | 2016-02-08 | 2017-08-17 | University Of Iowa Research Foundation | Methods to produce chimeric adeno-associated virus/bocavirus parvovirus |
MA43735A (en) | 2016-03-07 | 2018-11-28 | Univ Iowa Res Found | AAV MEDIATED EXPRESSION USING SYNTHETIC PROMOTER AND ACTIVATOR |
EP4140474A1 (en) * | 2021-08-23 | 2023-03-01 | Theracell Advanced Biotechnology S.A. | Nutraceutical for the reduction of osteoarthritic pain and inflammation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2187327B1 (en) * | 1972-06-15 | 1975-06-20 | Rech Pharm Scientifiques | |
US4315028A (en) * | 1978-12-22 | 1982-02-09 | Scheinberg Israel H | Method of treatment of rheumatoid arthritis |
US5120538A (en) * | 1990-02-05 | 1992-06-09 | Pt Darya-Varia Laboratoria | Combinations of compounds isolated from curcuma spp as anti-inflammatory agents |
DE4137540A1 (en) | 1991-11-14 | 1993-05-19 | Steigerwald Arzneimittelwerk | USE OF PREPARATIONS OF CURCUMA PLANTS |
WO1995022323A1 (en) | 1994-02-16 | 1995-08-24 | Idun Pharmaceuticals | Methods for controlling free radical generation by inflammatory cells |
US5494668A (en) | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
US5629351A (en) | 1995-04-13 | 1997-05-13 | Council Of Scientific & Industrial Research | Boswellic acid compositions and preparation thereof |
DE19531067A1 (en) | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Use of boswellic acid and its derivatives for inhibiting normal and increased leukocyte elastase or plasmin activity |
US5763496A (en) * | 1995-11-27 | 1998-06-09 | The Research Foundation Of State University Of New York | Prevention of atherosclerosis using NADPH oxidase inhibitors |
US5872124A (en) * | 1996-07-31 | 1999-02-16 | Thomas Jefferson University | Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite |
US5888514A (en) * | 1997-05-23 | 1999-03-30 | Weisman; Bernard | Natural composition for treating bone or joint inflammation |
-
2000
- 2000-09-14 US US09/662,123 patent/US6492429B1/en not_active Expired - Lifetime
-
2001
- 2001-07-10 WO PCT/NL2001/000525 patent/WO2002004003A2/en not_active Application Discontinuation
- 2001-07-10 EP EP01952054A patent/EP1347766A2/en not_active Withdrawn
- 2001-07-10 AU AU2001272849A patent/AU2001272849A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1347766A2 (en) | 2003-10-01 |
WO2002004003A3 (en) | 2003-07-31 |
WO2002004003A2 (en) | 2002-01-17 |
US6492429B1 (en) | 2002-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001272849A1 (en) | Composition for the treatment of osteoarthritis | |
AU2001268659A1 (en) | Water treatment compositions | |
AU2001272852A1 (en) | Composition for the treatment of migraine | |
AU2935200A (en) | Compounds for the treatment of obesity | |
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
AU2001233081A1 (en) | Composition for treatment of stress | |
AU2000258650A1 (en) | 2-piperidone compounds for the treatment of cancer | |
AU2001253749A1 (en) | 2-fluorobenzenesulfonyl compounds for the treatment of inflammation | |
AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
AU2001274877A1 (en) | Pest treatment composition | |
AU2002346882A1 (en) | Methods for the treatment of osteoarthritis and compositions thereof | |
AU1878201A (en) | Composition for the treatment of damaged tissue | |
AU2002365621A1 (en) | Composition for treating the surface of the skin | |
AU2002329441A1 (en) | Process for the preparation of 3 - isochromanone | |
AU2000231423A1 (en) | Specific therapeutic composition for treating aids | |
AU2002358085A1 (en) | Process for the preparation of 4-methyl-7-aminoquinolones | |
AU2683500A (en) | Compositions for the treatment of pain | |
AU2003240174A1 (en) | Compositions for the treatment of edematous-firbrosclerotic panniculopathy | |
AU2000272704A1 (en) | Use of compounds for the treatment of obesity | |
AU5462901A (en) | Process for the preparation of (pyridinylidene)-phthalides | |
AU5416500A (en) | Pharmaceutical composition for the treatment of calcification | |
AU2002324291A1 (en) | Process for the preparation of beta-ionylideneacetaldehyde | |
AU2000279379A1 (en) | An improved process for the preparation of 10h-phenoxazine | |
AU2000258438A1 (en) | An improved process for the preparation of acylferrocenes | |
AU2002221748A1 (en) | Stain treatment composition |